GLP-1 New Drug R&D Service: Physiological Actions of GLP 1s

GLP-1 shows numerous actions in different tissues and a broad therapeutic potential. The main actions of GLP-1 are to stimulate insulin secretion and to inhibit glucagon secretion, thereby contributing to limit postprandial glucose excursions. Learn more about GLP-1 New Drug R&D Service. GLP-1 also causes weight loss by increasing addition, GLP-1 also inhibits gastrointestinal motility and secretion and thus acts as an enterogastrone and part of the “ileal brake“ mechanism. Medicilon provides GLP-1 drug discovery, CMC research (API formulation), pharmacodynamics research, PK study, GLP-1 safety evaluation and other services.